Great Lakes Advisors LLC decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 13.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,421 shares of the company’s stock after selling 7,711 shares during the period. Great Lakes Advisors LLC’s holdings in Acadia Healthcare were worth $3,856,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of ACHC. FMR LLC lifted its position in shares of Acadia Healthcare by 117.7% during the first quarter. FMR LLC now owns 5,279,609 shares of the company’s stock worth $381,452,000 after purchasing an additional 2,854,393 shares in the last quarter. Hawk Ridge Capital Management LP boosted its position in Acadia Healthcare by 703.6% in the 1st quarter. Hawk Ridge Capital Management LP now owns 1,278,589 shares of the company’s stock valued at $92,378,000 after buying an additional 1,119,489 shares during the period. Wellington Management Group LLP grew its stake in shares of Acadia Healthcare by 17.8% in the first quarter. Wellington Management Group LLP now owns 5,626,846 shares of the company’s stock worth $406,540,000 after acquiring an additional 850,056 shares in the last quarter. Durable Capital Partners LP increased its position in shares of Acadia Healthcare by 30.8% during the fourth quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock worth $159,832,000 after acquiring an additional 457,687 shares during the period. Finally, Macquarie Group Ltd. raised its stake in shares of Acadia Healthcare by 826.5% in the first quarter. Macquarie Group Ltd. now owns 493,486 shares of the company’s stock valued at $35,654,000 after acquiring an additional 440,221 shares in the last quarter.
Insider Buying and Selling
In other Acadia Healthcare news, Director Debra K. Osteen sold 15,000 shares of the firm’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $74.21, for a total transaction of $1,113,150.00. Following the transaction, the director now owns 718,833 shares of the company’s stock, valued at $53,344,596.93. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, EVP John S. Hollinsworth sold 20,000 shares of the stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $73.00, for a total value of $1,460,000.00. Following the completion of the sale, the executive vice president now directly owns 177,130 shares of the company’s stock, valued at $12,930,490. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Debra K. Osteen sold 15,000 shares of Acadia Healthcare stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $74.21, for a total transaction of $1,113,150.00. Following the completion of the transaction, the director now directly owns 718,833 shares in the company, valued at $53,344,596.93. The disclosure for this sale can be found here. Insiders have sold 140,000 shares of company stock worth $10,350,325 in the last ninety days. 2.80% of the stock is owned by corporate insiders.
Acadia Healthcare Stock Down 0.1 %
Wall Street Analyst Weigh In
Several brokerages have weighed in on ACHC. Royal Bank of Canada cut their price target on Acadia Healthcare from $99.00 to $94.00 and set an “outperform” rating on the stock in a report on Tuesday, November 7th. TheStreet lowered shares of Acadia Healthcare from a “b” rating to a “c” rating in a research note on Friday, November 3rd. StockNews.com assumed coverage on shares of Acadia Healthcare in a research note on Thursday, October 5th. They issued a “hold” rating for the company. Finally, Cantor Fitzgerald increased their price objective on shares of Acadia Healthcare from $83.00 to $85.00 and gave the company a “neutral” rating in a research report on Thursday, September 14th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $85.71.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilities, and outpatient clinics.
- Five stocks we like better than Acadia Healthcare
- How to Calculate Return on Investment (ROI)
- Safeguard your portfolio with these three bargain stocks
- NYSE Stocks Give Investors a Variety of Quality Options
- Membership clubs gain leverage for the consumer rebound
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Advanced Auto Parts may be worth more in pieces than the whole
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.